These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 10624419)

  • 1. Changing trends in cytomegalovirus retinitis with highly active anti-retroviral therapy (HAART).
    Dhillon B; Ramaesh K; Leen C
    Eye (Lond); 1999 Jun; 13 ( Pt 3a)():275-6. PubMed ID: 10624419
    [No Abstract]   [Full Text] [Related]  

  • 2. Characterization of reactivation of cytomegalovirus retinitis in patients healed after treatment with highly active antiretroviral therapy.
    Song MK; Karavellas MP; MacDonald JC; Plummer DJ; Freeman WR
    Retina; 2000; 20(2):151-5. PubMed ID: 10783947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-HIV drugs allow immune system to rebound, fight CMV.
    Optom Vis Sci; 2000 Jan; 77(1):3. PubMed ID: 10654853
    [No Abstract]   [Full Text] [Related]  

  • 4. Discontinuation of secondary prophylaxis in patients with cytomegalovirus retinitis who have responded to highly active antiretroviral therapy.
    Berenguer J; González J; Pulido F; Padilla B; Casado JL; Rubio R; Arribas JR;
    Clin Infect Dis; 2002 Feb; 34(3):394-7. PubMed ID: 11753827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of cytomegalovirus-specific CD4+ T cell responses in human immunodeficiency virus type 1-infected patients with high CD4+ T cell counts and recurrent retinitis.
    Komanduri KV; Feinberg J; Hutchins RK; Frame RD; Schmidt DK; Viswanathan MN; Lalezari JP; McCune JM
    J Infect Dis; 2001 Apr; 183(8):1285-9. PubMed ID: 11262214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sustained cytomegalovirus-specific CD4+ T cell response associated with prevention of recurrence of cytomegalovirus retinitis without secondary prophylaxis after highly active antiretroviral therapy in patients with AIDS.
    Tanaka M; Yasuoka C; Genka I; Tachikawa N; Kikuchi Y; Teruya K; Yasuoka A; Hirabayashi Y; Kimura S; Oka S
    AIDS Res Hum Retroviruses; 2001 Dec; 17(18):1749-56. PubMed ID: 11788026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of untreated AIDS-related cytomegalovirus retinitis. II. Findings in the era of highly active antiretroviral therapy (1997 to 2000).
    Holland GN; Vaudaux JD; Shiramizu KM; Yu F; Goldenberg DT; Gupta A; Carlson M; Read RW; Novack RD; Kuppermann BD;
    Am J Ophthalmol; 2008 Jan; 145(1):12-22. PubMed ID: 18154751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy.
    Stein DS
    Lancet; 1997 Aug; 350(9077):589-90. PubMed ID: 9284796
    [No Abstract]   [Full Text] [Related]  

  • 9. Association of cytomegalovirus (CMV)-specific CD4+ T lymphocyte reactivity and protective immunity against acquired immunodeficiency syndrome-related CMV retinitis.
    Jacobson MA; Bredt BM
    J Infect Dis; 2002 Dec; 186(11):1701-2; author reply 1702-3. PubMed ID: 12447752
    [No Abstract]   [Full Text] [Related]  

  • 10. Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy.
    Carr A; Cooper DA
    Lancet; 1997 Aug; 350(9077):589; author reply 590. PubMed ID: 9284795
    [No Abstract]   [Full Text] [Related]  

  • 11. Discontinuation of maintenance therapy in patients with quiescent cytomegalovirus retinitis and elevated CD4+ counts.
    Vrabec TR; Baldassano VF; Whitcup SM
    Ophthalmology; 1998 Jul; 105(7):1259-64. PubMed ID: 9663231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Negative result of cytomegalovirus blood culture with restoration of CD4+ T-cell reactivity to cytomegalovirus after HAART in an HIV-1-infected patient.
    Li TS; Tubiana R; Fillet AM; Autran B; Katlama C
    J Acquir Immune Defic Syndr Hum Retrovirol; 1999 Apr; 20(5):514-5. PubMed ID: 10225236
    [No Abstract]   [Full Text] [Related]  

  • 13. Stopping CMV prophylaxis with HAART.
    TreatmentUpdate; 1998 Sep; 10(7):4-6. PubMed ID: 11365782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy.
    Stricker RB; Goldberg B
    Lancet; 1997 Aug; 350(9077):589; author reply 590. PubMed ID: 9284794
    [No Abstract]   [Full Text] [Related]  

  • 15. Control of cytomegalovirus retinitis after combination antiretroviral therapy.
    Ruhswurm I; Ries E; Krepler K; Derbolav A; Rieger A; Armbruster C; Wedrich A
    Acta Ophthalmol Scand; 1999 Aug; 77(4):471-3. PubMed ID: 10463426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytomegalovirus (CMV)-specific CD4+ T lymphocyte immune function in long-term survivors of AIDS-related CMV end-organ disease who are receiving potent antiretroviral therapy.
    Jacobson MA; Schrier R; McCune JM; Torriani FJ; Holland GN; O'Donnell JJ; Freeman WR; Bredt BM
    J Infect Dis; 2001 May; 183(9):1399-404. PubMed ID: 11294673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CMV after HAART.
    Posit Aware; 1998; 9(5):18, 23. PubMed ID: 11365888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy.
    Mitchell SM; Youle MS; Membrey WL; Jones CD
    Lancet; 1997 Aug; 350(9077):588; author reply 590. PubMed ID: 9284792
    [No Abstract]   [Full Text] [Related]  

  • 19. Changing trends in cytomegalovirus retinitis with triple therapy.
    Lee V; Subak-Sharpe I; Shah S; Aitken C; Limb S; Pinching A
    Eye (Lond); 1999; 13 ( Pt 1)():59-64. PubMed ID: 10396386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between cytomegalovirus-specific reactivity of T cell subsets and development of cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome.
    Hsieh SM; Pan SC; Hung CC; Tsai HC; Chen MY; Chang SC
    J Infect Dis; 2001 Dec; 184(11):1386-91. PubMed ID: 11709780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.